These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13121613)

  • 1. [Results of tests of resistance and essay of two antibiotics; ilotycin and magnamycin].
    RESSELER J
    Rev Belg Pathol Med Exp; 1953 Jul; 23(1):14-9. PubMed ID: 13121613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of resistance tests and trials of two new antibiotics, ilotycin and magnamycin].
    RESSELER J; BRUYNOGHE G
    Acta Clin Belg; 1953; 8(4):488-9. PubMed ID: 13104053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemistry and technology of antibiotic production; secretion, purification and chemical nature of antibiotics of the erythromycin group, of magnamycin; review of foreign periodical literature].
    TRAKHTENBERG DM
    Antibiotiki; 1956; 9(5):22-36. PubMed ID: 24544245
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial spectrum of erythromycin, carbomycin, chloramphenicol, aureomycin, and terramycin.
    WELCH H; RANDALL WA; REEDY RJ; KRAMER J
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):693-6. PubMed ID: 24542160
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M; JONES WF; NICHOLS RL
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-correlation of bacterial sensitivity to carbomycin and erythromycin compared with other antibiotics.
    KUTSCHER AH; SEGUIN L; LEWIS S; PIRO JD; ZEGARELLI EV; RANKOW R; SEGALL R
    Antibiot Chemother (Northfield); 1954 Oct; 4(10):1023-36. PubMed ID: 24543236
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross resistance to antibiotics: effect of exposures of bacteria to carbomycin or erythromycin in vitro.
    FINLAND M; WILCOX C; WRIGHT SS; PURCELL EM
    Proc Soc Exp Biol Med; 1952 Dec; 81(3):725-9. PubMed ID: 13037779
    [No Abstract]   [Full Text] [Related]  

  • 8. Induced resistance of staphylococci to carbomycin and erythromycin.
    RAJAM PC; ADCOCK JD
    Med Bull (Ann Arbor); 1953 Aug; 19(8):212-7. PubMed ID: 13090461
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of the sensitivity in vitro of Actinomyces israeli to erythromycin, magnamycin, polymyxin B, bacitracin, neomycin, tyrothricin, xanthocillin and suprathricin].
    HANF U
    Z Hyg Infektionskr; 1956; 143(2):127-33. PubMed ID: 13401963
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnamycin. II. In vivo studies.
    ENGLISH AR; MULLADY HE; FITTS RA
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):94-8. PubMed ID: 24542283
    [No Abstract]   [Full Text] [Related]  

  • 11. Some properties of magnamycin; a new antibiotic.
    TANNER FW; ENGLISH AR; LEES TM; ROUTIEN JB
    Antibiot Chemother (Northfield); 1952 Sep; 2(9):441-3. PubMed ID: 24542077
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnamycin, a new antibiotic.
    FINN JJ; KANE LW
    Bull New Engl Med Cent; 1952; 14(4):113-6. PubMed ID: 13009389
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnamycin. I. In vitro studies.
    ENGLISH AR; FIELD MF; SZENDY SR; TAGLIANI NJ; FITTS RA
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):678-88. PubMed ID: 24542158
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnamycin: toxicity in experimental animals.
    GARDOCKI JF; P'AN SY; RAPUZZI AL; FANELLI GM; TIMMENS EK
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):55-62. PubMed ID: 24542279
    [No Abstract]   [Full Text] [Related]  

  • 15. Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin).
    HEILMAN FR; HERRELL WE; WELLMAN WE; GERACI JE
    Proc Staff Meet Mayo Clin; 1952 Jul; 27(15):285-304. PubMed ID: 14941877
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R; NUSSER W
    Antibiot Annu; 1955-1956; 3():773-7. PubMed ID: 13355361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ilotycin, a new antibiotic].
    MCGUIRE JM; BUNCH RL; ANDERSON RC; BOAZ HE; FLYNN EH; POWELL HM; SMITH JW
    Schweiz Med Wochenschr; 1952 Oct; 82(41):1064-5. PubMed ID: 13015030
    [No Abstract]   [Full Text] [Related]  

  • 18. Ilotycin, a new antibiotic.
    McGUIRE JM; BUNCH RL; ANDERSON RC; BOAZ HE; FLYNN EH; POWELL HM; SMITH JW
    Antibiot Chemother (Northfield); 1952 Jun; 2(6):281-3. PubMed ID: 24541924
    [No Abstract]   [Full Text] [Related]  

  • 19. The toxicity and distribution of ilotycin.
    ANDERSON RC; HARRIS PN; CHEN KK
    J Am Pharm Assoc Am Pharm Assoc; 1952 Oct; 41(10):555-9. PubMed ID: 12999613
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and laboratory experience with carbomycin].
    HEWIT W
    Dia Med; 1952 Dec; 24(90):2335-8. PubMed ID: 13033598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.